Related Experiment Video
Updated: Mar 6, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
PI3Kα isoform-dependent activation of RhoA regulates Wnt5a-induced osteosarcoma cell migration
Ailiang Zhang1, Ting Yan2, Kun Wang1
1Spine Surgery, Third Affiliated Hospital of Soochow University, Changzhou, 213003 Jiangsu China.
Background:
We have reported that the phosphatidylinositol-3 kinase (PI3K)/Akt signaling pathway mediated Wnt5a-induced osteosarcoma cell migration. However, the signaling pathways regulating Wnt5a/PI3K/Akt-mediated cell migration remains poorly defined in osteosarcoma cells.
Methods:
We evaluated the activations of RhoA, Rac1 and Cdc42 in osteosarcoma MG-63 and U2OS cells with small G-protein activation assay. Boyden chamber assays were used to confirm the migration of cells transfected indicated constructs or siRNA specific against RhoA. A panel of inhibitors of PI3K and Akt treated osteosarcoma cells and blocked kinase activity. Western blotting and RhoA activation assay were employed to measure the effect of kinase inhibitors and activations of RhoA and Akt.
Results:
We found that Wnt5a had a potent stimulatory effect on RhoA activation, but not on Rac1 and Cdc42 activations. Wnt5a-induced cell migration was largely abolished by siRNA specific against RhoA. DN-RhoA (GFP-RhoA-N19) was also capable of retarding Wnt5a-induced cell migration, but the overexpression of CA-RhoA (GFP-RhoA-V14) was not able to accelerate cell migration. The Wnt5a-induced activation of RhoA was mostly blocked by pretreatment of LY294002 (PI3K inhibitor) and MK-2206 (Akt inhibitor). Furthermore, we found that the Wnt5a-induced activation of RhoA was mostly blocked by pretreatment of HS-173 (PI3Kα inhibitor). Lastly, the phosphorylation of Akt (p-Ser473) was not altered by transfection with siRNA specific against RhoA or DN-RhoA (GFP-RhoA-N19).
Conclusions:
Taken together, we demonstrate that RhoA acts as the downstream of PI3K/Akt signaling (specific PI3Kα, Akt1 and Akt2 isoforms) and mediated Wnt5a-induced the migration of osteosarcoma cells.
Insights
This study reveals that RhoA is a key mediator of Wnt5a-induced osteosarcoma cell migration, acting downstream of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway. Understanding this pathway is crucial for targeting osteosarcoma progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The phosphatidylinositol-3 kinase (PI3K)/Akt pathway is known to mediate Wnt5a-induced osteosarcoma cell migration.
- However, the precise signaling mechanisms downstream of Wnt5a/PI3K/Akt in osteosarcoma cell migration remain unclear.
Purpose of the Study:
- To elucidate the role of RhoA, Rac1, and Cdc42 in Wnt5a-induced osteosarcoma cell migration.
- To investigate the relationship between Wnt5a, PI3K/Akt signaling, and RhoA activation in osteosarcoma cells.
Main Methods:
- Utilized small G-protein activation assays to measure RhoA, Rac1, and Cdc42 activity in osteosarcoma cell lines (MG-63, U2OS).
- Employed Boyden chamber assays to assess cell migration following transfection with specific constructs or siRNAs.
- Applied PI3K and Akt inhibitors (LY294002, MK-2206, HS-173) and Western blotting to analyze signaling pathway modulation.
Main Results:
- Wnt5a significantly stimulated RhoA activation, but not Rac1 or Cdc42, in osteosarcoma cells.
- RhoA depletion or inhibition substantially reduced Wnt5a-induced cell migration.
- Wnt5a-induced RhoA activation was blocked by PI3K and Akt inhibitors, including a specific PI3Kα inhibitor (HS-173).
- Akt phosphorylation was unaffected by RhoA manipulation, indicating RhoA acts downstream of Akt.
Conclusions:
- RhoA is a critical downstream effector of Wnt5a-induced osteosarcoma cell migration.
- The Wnt5a/PI3K/Akt signaling pathway regulates osteosarcoma cell migration through RhoA activation.
- Targeting the PI3Kα/Akt/RhoA axis presents a potential therapeutic strategy for osteosarcoma.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway

